home All News open_in_new Full Article

EEUU aprueba una nueva forma de prevención contra el VIH mediante un tratamiento inyectable dos veces al año

La FDA da luz verde a lenacapavir un inyectable semestral que evita la infección en casi el 100% de los casos Leer


today 20 h. ago attach_file Politics

attach_file Politics
attach_file Events
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Science
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Events


ID: 486066803
Add Watch Country

arrow_drop_down